Glenmark Pharma reports 30% rise in Q3 consolidated net profit

13 Feb 2021 Evaluate

Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2020.

The company has reported a rise of 28.01% in its net profit from continuing operations at Rs 442.33 crore for the quarter under review as compared to net profit at Rs 345.53 crore for the same quarter in the previous year. Total income of the company increased by 7.47% at Rs 2,053.61 crore for Q3FY21 as compared Rs 1,910.78 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 30.05% in its net profit continuing operations at Rs 248.18 crore for the quarter under review as compared to net profit at Rs 190.84 crore for the same quarter in the previous year. Total income of the company increased by 1.20% at Rs 2,801.85 crore for Q3FY21 as compared Rs 2,768.52 crore for the corresponding quarter previous year.

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×